Samir H. Barghout

914 total citations
20 papers, 272 citations indexed

About

Samir H. Barghout is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Samir H. Barghout has authored 20 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Hematology. Recurrent topics in Samir H. Barghout's work include Protein Degradation and Inhibitors (9 papers), Ubiquitin and proteasome pathways (7 papers) and Histone Deacetylase Inhibitors Research (6 papers). Samir H. Barghout is often cited by papers focused on Protein Degradation and Inhibitors (9 papers), Ubiquitin and proteasome pathways (7 papers) and Histone Deacetylase Inhibitors Research (6 papers). Samir H. Barghout collaborates with scholars based in Canada, Egypt and United States. Samir H. Barghout's co-authors include Aaron D. Schimmer, Dalia Baršytė-Lovejoy, Yangxin Fu, Zhihua Xu, Helen Steed, Raquel A. C. Machado, Cheng‐Han Lee, Lynne‐Marie Postovit, Abul Kalam Azad and Christine Yang and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Pharmacological Reviews.

In The Last Decade

Samir H. Barghout

17 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samir H. Barghout Canada	9	220	63	42	30	25	20	272
Limin Huang China	8	157 0.7×	65 1.0×	96 2.3×	33 1.1×	24 1.0×	22	311
Upasana Bedi Germany	9	410 1.9×	90 1.4×	73 1.7×	15 0.5×	34 1.4×	9	472
Jennifer Zlott United States	5	250 1.1×	162 2.6×	33 0.8×	11 0.4×	35 1.4×	18	329
Dong Yin United States	5	380 1.7×	158 2.5×	49 1.2×	17 0.6×	22 0.9×	5	425
Mary J. Pulvino United States	9	315 1.4×	70 1.1×	58 1.4×	32 1.1×	7 0.3×	12	376
Enilze M.S.F. Ribeiro Brazil	10	208 0.9×	56 0.9×	141 3.4×	14 0.5×	25 1.0×	22	303
Mathias Orban Germany	5	483 2.2×	155 2.5×	55 1.3×	16 0.5×	16 0.6×	5	538
Grace Wing-Yan Mak Hong Kong	6	128 0.6×	57 0.9×	33 0.8×	15 0.5×	12 0.5×	8	175

Countries citing papers authored by Samir H. Barghout

Since Specialization

Citations

This map shows the geographic impact of Samir H. Barghout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir H. Barghout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir H. Barghout more than expected).

Fields of papers citing papers by Samir H. Barghout

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir H. Barghout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir H. Barghout. The network helps show where Samir H. Barghout may publish in the future.

Co-authorship network of co-authors of Samir H. Barghout

This figure shows the co-authorship network connecting the top 25 collaborators of Samir H. Barghout. A scholar is included among the top collaborators of Samir H. Barghout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samir H. Barghout. Samir H. Barghout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barghout, Samir H. & Mohamed A. Eldeeb. (2025). Emerging pharmacology of targeted protein degraders. Journal of Pharmacology and Experimental Therapeutics. 392(12). 103694–103694.

Chan, Sze Wah Samuel, Samir H. Barghout, Stavroula Raptis, et al.. (2024). A Poor Prognostic ALK Phenotype: A Review of Molecular Markers of Poor Prognosis in ALK Rearranged Nonsmall Cell Lung Cancer. Clinical Lung Cancer. 26(1). e22–e32.e2. 2 indexed citations

Szewczyk, Magdalena M., et al.. (2023). HiBiT Cellular Thermal Shift Assay (HiBiT CETSA). Methods in molecular biology. 2706. 149–165. 5 indexed citations

Chan, Sze Wah Samuel, M. Catherine Brown, Jae Lee, et al.. (2023). Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence. Cancer Treatment and Research Communications. 37. 100774–100774.

Barghout, Samir H., Mandeep Mann, Asma M. Aman, et al.. (2022). Combinatorial Anticancer Drug Screen Identifies Off-Target Effects of Epigenetic Chemical Probes. ACS Chemical Biology. 17(10). 2801–2816. 7 indexed citations

Barghout, Samir H., Raquel A. C. Machado, & Dalia Baršytė-Lovejoy. (2022). Chemical biology and pharmacology of histone lysine methylation inhibitors. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1865(6). 194840–194840. 20 indexed citations

Szewczyk, Magdalena M., Genna M. Luciani, Victoria Vu, et al.. (2022). PRMT5 regulates ATF4 transcript splicing and oxidative stress response. Redox Biology. 51. 102282–102282. 22 indexed citations

Chow, Sue, et al.. (2022). Combined Targeting of the Glutathione and Thioredoxin Antioxidant Systems in Pancreatic Cancer. ACS Pharmacology & Translational Science. 5(11). 1070–1078. 9 indexed citations

Barghout, Samir H.. (2022). New Frontiers in the Discovery and Development of PROTACs. Anti-Cancer Agents in Medicinal Chemistry. 22(15). 2656–2661. 5 indexed citations

10.

Barghout, Samir H., Asma M. Aman, Kazem Nouri, et al.. (2021). A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity. JCI Insight. 6(5). 24 indexed citations

11.

Song, Ling, Jessica Weiss, Kevin C. Nixon, et al.. (2021). The First-in-Class UBA1 Inhibitor, TAK-243, in Combination With Radiotherapy for YAP1 and BEND3 Biomarker-Defined Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 111(3). e467–e467. 1 indexed citations

12.

Barghout, Samir H. & Aaron D. Schimmer. (2020). E1 Enzymes as Therapeutic Targets in Cancer. Pharmacological Reviews. 73(1). 1–58. 74 indexed citations

13.

Barghout, Samir H.. (2020). Targeted Protein Degradation: An Emerging Therapeutic Strategy in Cancer. Anti-Cancer Agents in Medicinal Chemistry. 21(2). 214–230. 16 indexed citations

14.

Barghout, Samir H., Neil MacLean, G. Wei Xu, et al.. (2018). A Genome-Wide CRISPR/Cas9 Knockout Screen Identifies BEND3 As a Determinant of Sensitivity to UBA1 Inhibition in Acute Myeloid Leukemia. Blood. 132(Supplement 1). 1350–1350. 1 indexed citations

15.

Singh, Rashim Pal, Danny V. Jeyaraju, Véronique Voisin, et al.. (2018). Targeting the Mitochondrial Metallochaperone Cox17 Reduces DNA Methylation and Promotes AML Differentiation through a Copper Dependent Mechanism. Blood. 132(Supplement 1). 1339–1339. 4 indexed citations

16.

Hurren, Rose, Mark R. Albertella, Marcela Gronda, et al.. (2018). The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia. Haematologica. 104(5). 963–972. 17 indexed citations

17.

Barghout, Samir H., Parasvi S. Patel, Xiaoming Wang, et al.. (2017). TAK-243 Is a Selective UBA1 Inhibitor That Displays Preclinical Activity in Acute Myeloid Leukemia (AML). Blood. 130(Suppl_1). 814–814.

18.

Jeyaraju, Danny V., Véronique Voisin, Changjiang Xu, et al.. (2017). Inhibiting the Mitochondrial Sulfhydryl Oxidase Alr Reduces Cox17 and Alters Mitochondrial Cristae Structure Leading to the Differentiation of AML and Stem Cells. Blood. 130(Suppl_1). 881–881. 1 indexed citations

19.

Barghout, Samir H., Krista M. Vincent, Abul Kalam Azad, et al.. (2015). RUNX3 contributes to carboplatin resistance in epithelial ovarian cancer cells. Gynecologic Oncology. 138(3). 647–655. 28 indexed citations

20.

Barghout, Samir H., et al.. (2015). Elevated β-catenin activity contributes to carboplatin resistance in A2780cp ovarian cancer cells. Biochemical and Biophysical Research Communications. 468(1-2). 173–178. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact